PharmacyCodes



Tomoxetina [Spanish] en es it fr

Tomoxetina [Spanish] Brand names, Tomoxetina [Spanish] Analogs

Tomoxetina [Spanish] Brand Names Mixture

  • No information avaliable

Tomoxetina [Spanish] Chemical_Formula

C17H21NO

Tomoxetina [Spanish] RX_link

http://www.rxlist.com/cgi/generic3/strattera.htm

Tomoxetina [Spanish] fda sheet

Tomoxetina_[Spanish] FDA

Tomoxetina [Spanish] msds (material safety sheet)

Tomoxetina [Spanish] Synthesis Reference

No information avaliable

Tomoxetina [Spanish] Molecular Weight

255.355 g/mol

Tomoxetina [Spanish] Melting Point

No information avaliable

Tomoxetina [Spanish] H2O Solubility

No information avaliable

Tomoxetina [Spanish] State

Solid

Tomoxetina [Spanish] LogP

4.656

Tomoxetina [Spanish] Dosage Forms

Capsule

Tomoxetina [Spanish] Indication

For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).

Tomoxetina [Spanish] Pharmacology

Atomoxetine is an amphetamine used to treat ADD/ADHD in children and adults. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. It increases motor activity and mental alertness, and reduces drowsiness and a sense of fatigue, decreasing motor restlessness and improves one's ability to focus. Peripheral actions include elevation of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. There is neither specific evidence which clearly establishes the mechanism whereby amphetamine produces mental and behavioral effects in children, nor conclusive evidence regarding how these effects relate to the condition of the central nervous system. Atomoxetine activates the brain stem arousal system and cortex to produce its stimulant effect.

Tomoxetina [Spanish] Absorption

No information avaliable

Tomoxetina [Spanish] side effects and Toxicity

No information avaliable

Tomoxetina [Spanish] Patient Information

Tomoxetina [Spanish] Organisms Affected

Humans and other mammals